ARCH Venture Fund IX L.P. 13D and 13G filings for Karuna Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-20 4:58 pm Sale | 2022-08-12 | 13D | Karuna Therapeutics, Inc. KRTX | ARCH Venture Fund IX L.P. | 0 0.000% | -2,946,891 (Position Closed) | Filing |
| 2021-04-22 7:22 pm Sale | 2021-04-13 | 13D | Karuna Therapeutics, Inc. KRTX | ARCH Venture Fund IX L.P. | 2,946,891 10.000% | -135,744 (-4.40%) | Filing |
| 2021-01-19 1:25 pm Sale | 2021-01-08 | 13D | Karuna Therapeutics, Inc. KRTX | ARCH Venture Fund IX L.P. | 3,082,635 11.500% | -280,237 (-8.33%) | Filing |